- 24 h
- letzte 200 News
| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| Fr | FDA names 28 antibody tests to be taken off the market | ||
| Fr | Inovio CEO on the COVID-19 vaccine race: Don't count us out | ||
| Fr | Syndax cans FDA filing for lead cancer med after breast cancer bust | ||
| Fr | Genentech posts long-term data on near-approval Soliris rival | ||
| Fr | Chutes & Ladders-Warp Speed's Slaoui sells $12M in Moderna stock | ||
| Fr | AstraZeneca's COVID-19 vaccine enters phase 2/3 clinical trial | ||
| Fr | This cancer-related gene may also hold the key to beating obesity | ||
| Do | GSK taps Mammoth Biosciences to develop a CRISPR-based, over-the-counter coronavirus test | ||
| Do | Kadmon's graft-versus-host disease med on track for 2020 filing | ||
| Do | Nautilus emerges with $76M to become the 'Illumina of proteomics' | ||
| Do | Harvard animal studies suggest COVID-19 protection can come from previous infection or DNA vaccine | ||
| Do | SR One fuels HotSpot's $65M B round to fund allosteric R&D | ||
| Do | Day One debuts with $60M to change cancer care-starting with children | ||
| Do | Gilead's filgotinib phase 3 hits primary endpoint but details dampen hopes | ||
| Mi | CanSino adds mRNA to COVID-19 vaccine efforts with Precision NanoSystems deal | ||
| Mi | Apple, Google roll out COVID-19 contact tracing software kit | ||
| Mi | It's too soon to assume success for Moderna's COVID-19 vaccine: analyst | ||
| Mi | Color gets green light for LAMP-based COVID-19 screening test | ||
| Mi | Eiger's progeria drug nabs speedy review | ||
| Mi | Atea raises $215M to support midphase COVID-19 antiviral trial | ||
| Mi | AstraZeneca-partnered RNA player Silence plans Nasdaq listing | ||
| Di | FDA, Aetion dive into the real-world data surrounding COVID-19 | ||
| Di | Pandion recruits Gilead alum Sundy as CMO | ||
| Di | Cell therapy repairs multiple sclerosis damage and restores motor functions in mice | ||
| Di | Inflammatory disease biotech Applied Molecular Transport aims for $100M IPO |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
